
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zurich, Switzerland and Concord, MA, USA
Darpins,oncology,immuno-oncology,radiopharmaceuticals,immunology and other indications,virology,ophthalmology,intellectual property of darpins,repeat proteins and protein engineering,and collaborations with other leading pharmaceutical companies
Molecular partners operates in the Biotechnology research industry.
Molecular partners's revenue is 1m - 10m
Molecular partners has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.